Halozyme Therapeutics HALO PEG ratio
PEG ratio at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Halozyme Therapeutics’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's peg ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Halozyme Therapeutics's PEG ratio?
- Halozyme Therapeutics (HALO) reported PEG ratio of 0.3× in Q3 2025.
- How has Halozyme Therapeutics's PEG ratio changed year-over-year?
- Halozyme Therapeutics's PEG ratio decreased by 18.0% year-over-year, from 0.3× to 0.3×.
- What is the long-term trend for Halozyme Therapeutics's PEG ratio?
- Over 2 years (2021 to 2024), Halozyme Therapeutics's PEG ratio has grown at a 91.4% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does PEG ratio mean?
- The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.